Abstract
This cohort study explores whether clinician specialty and patient familiarity with the attending clinician are associated with rates of low-dose computerized tomographic lung cancer screening after shared decision-making visits.
Highlights
The United States Preventive Services Task Force has recommended[1] and the Centers for Medicare & Medicaid Services has mandated[2] a separate visit in which a clinician and the patient participate in shared decision-making (SDM) prior to deciding on low-dose computerized tomographic (LDCT) screening for lung cancer.The purpose of this study was to determine whether the rate of subsequent LDCT screening is associated with the type of clinician visited and with whether the clinician had a prior relationship with the patient.Author affiliations and article information are listed at the end of this article
The decision to undergo LDCT lung cancer screening varies substantially by the clinician participating in the SDM
We found that SDM with a clinician with prior experience with the patient led to substantially lower rates of LDCT (55% vs 75%)
Summary
The United States Preventive Services Task Force has recommended[1] and the Centers for Medicare & Medicaid Services has mandated[2] a separate visit in which a clinician and the patient participate in shared decision-making (SDM) prior to deciding on low-dose computerized tomographic (LDCT) screening for lung cancer.The purpose of this study was to determine whether the rate of subsequent LDCT screening is associated with the type of clinician visited and with whether the clinician had a prior relationship with the patient.Author affiliations and article information are listed at the end of this article.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
